Leef Brands (LEEEF) Free Cash Flow (2025 - 2026)
Leef Brands' (LEEEF) quarterly Free Cash Flow came in at -$99838.0 in Q1 2026, up 95.0% year-on-year from -$51198.0 in Q1 2025, and up 95.0% quarter-over-quarter from -$2.0 million in Q1 2025.
Leef Brands (LEEEF) Free Cash Flow (2025 - 2026) Analysis & Trends
Leef Brands has disclosed Free Cash Flow across 2 years of filings, most recently posting -$99838.0 for Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$99838.0, up 95.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.1 million (changed N/A YoY), and the FY2025 annual result was -$978909.0, up 85.95% from the prior year.
- Free Cash Flow came in at -$99838.0 for Q1 2026 at Leef Brands, up from -$2.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$99838.0 in Q1 2026 to a low of -$2.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Leef Brands | - | - | 4.62 Mn | -99,838.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99,838.00 |
| Mar 31, 2026 | -99,838.00 |
| Mar 31, 2025 | -2.00 Mn |
| Mar 31, 2025 | -2.00 Mn |